(Circulation. 1995;91:16-19.)
© 1995 American Heart Association, Inc.
Articles |
Relevance of Blockade of Cardiac and Circulatory Angiotensin-Converting Enzyme for the Prevention of Volume Overload–Induced Cardiac Hypertrophy
From the Hypertension Unit, University of Ottawa Heart Institute, 1053 Carling Ave, Ottawa, Ontario, Canada, K1Y 4E9.
Correspondence to Hypertension Unit, University of Ottawa Heart Institute, 1053 Carling Ave, Ottawa, Ontario, Canada K1Y 4E9.
Background Angiotensin-converting enzyme (ACE) inhibitors show major differences in their affinity for cardiac and other tissue ACEs, and their effects on tissue ACE range from minimal to nearly complete blockade. Angiotensin II taken up from the circulation or generated in the heart may mediate the cardiac hypertrophic response to increased cardiac load. Thus, differences between the ACE inhibitors regarding their effects on cardiac ACE may determine their effects on prevention or regression of cardiac hypertrophy.
Methods and Results In the present study, we assessed the effects of ACE inhibitors with low (enalapril) and high (quinapril) affinity for cardiac tissue ACE on prevention of volume overload–induced cardiac hypertrophy in relation to their hemodynamic effects. Both blockers were equipotent for circulatory ACE as assessed from the pressure response curve to angiotensin I. Both blockers partially (and similarly) prevented the increase in left ventricular end-diastolic pressure by aortocaval shunt. However, only quinapril prevented or attenuated the development of right ventricular hypertrophy and left ventricular hypertrophy and dilation.
Conclusions The present findings further stress the involvement of the renin-angiotensin system as a trophic stimulus in the development of cardiac hypertrophy in this model. Moreover, the low affinity of enalapril for cardiac ACE appears to lead to continuous angiotensin II generation in the heart and can thus explain the failure of enalapril to attenuate hypertrophic response of the heart induced by shunt despite decreasing cardiac volume overload.
Key Words: angiotensin • hypertrophy • enzymes • volume overload
This article has been cited by other articles:
 |
|
 |
|
  G. L. Brower, S. P. Levick, and J. S. Janicki Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3057 - H3064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-L. Tian, Y. M. Pinto, O. Costerousse, W. M. Franz, A. Lippoldt, S. Hoffmann, T. Unger, and M. Paul Over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats Hum. Mol. Genet., July 15, 2004; 13(14): 1441 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, E. Sentex, D. Chapman, and N. S. Dhalla Alterations of adenylyl cyclase and G proteins in aortocaval shunt-induced heart failure Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H118 - H125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. U Braun, P. Szalai, R. H Strasser, and M. M Borst Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes Cardiovasc Res, September 1, 2003; 59(3): 658 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sakata, K. Yamamoto, T. Mano, N. Nishikawa, J. Yoshida, T. Miwa, M. Hori, and T. Masuyama Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction Cardiovasc Res, March 1, 2003; 57(3): 757 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. U Braun, P. LaRosee, S. Schon, M. M Borst, and R. H Strasser Differential regulation of cardiac protein kinase C isozyme expression after aortic banding in rat Cardiovasc Res, October 1, 2002; 56(1): 52 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Perry, T. Mori, C.-C. Wei, X. Y. Xu, Y.-F. Chen, S. Oparil, P. Lucchesi, and L. J. Dell'Italia Genetic Variation in Angiotensin-Converting Enzyme Does Not Prevent Development of Cardiac Hypertrophy or Upregulation of Angiotensin II in Response to Aortocaval Fistula Circulation, February 20, 2001; 103(7): 1012 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. H. Leenen, V. Skarda, B. Yuan, and R. White Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H317 - H325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mazzolai, J. Nussberger, J.-F. Aubert, D. B. Brunner, G. Gabbiani, H. R. Brunner, and T. Pedrazzini Blood Pressure–Independent Cardiac Hypertrophy Induced by Locally Activated Renin-Angiotensin System Hypertension, June 1, 1998; 31(6): 1324 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kyriakidis, F. Triposkiadis, J. Dernellis, A. E. Androulakis, P. Mellas, G. A. Kelepeshis, and J. E. Gialafos Effects of Cardiac Versus Circulatory Angiotensin-Converting Enzyme Inhibition on Left Ventricular Diastolic Function and Coronary Blood Flow in Hypertrophic Obstructive Cardiomyopathy Circulation, April 14, 1998; 97(14): 1342 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wickman, P. Friberg, M. A. Adams, G. L. Matejka, C. Brantsing, G. Guron, and J. Isgaard Induction of Growth Hormone Receptor and Insulin-Like Growth Factor-I mRNA in Aorta and Caval Vein During Hemodynamic Challenge Hypertension, January 1, 1997; 29(1): 123 - 130. [Abstract] [Full Text]
|
|
|
|
|
|
M. Ruzicka, V. Skarda, and F. H.H. Leenen Effects of ACE Inhibitors on Circulating Versus Cardiac Angiotensin II in Volume OverloadInduced Cardiac Hypertrophy in Rats Circulation, December 15, 1995; 92(12): 3568 - 3573. [Abstract] [Full Text]
|
|
|
|
|
|
F. Pieruzzi, Z. A. Abassi, and H. R. Keiser Expression of Renin-Angiotensin System Components in the Heart, Kidneys, and Lungs of Rats With Experimental Heart Failure Circulation, November 15, 1995; 92(10): 3105 - 3112. [Abstract] [Full Text]
|
|
|
|
|
|
A. Calderone, N. Takahashi, N. J. Izzo Jr, C. M. Thaik, and W. S. Colucci Pressure- and Volume-Induced Left Ventricular Hypertrophies Are Associated With Distinct Myocyte Phenotypes and Differential Induction of Peptide Growth Factor mRNAs Circulation, November 1, 1995; 92(9): 2385 - 2390. [Abstract] [Full Text]
|
|
|
|
|
|
N. Iwai, H. Shimoike, and M. Kinoshita Cardiac Renin-Angiotensin System in the Hypertrophied Heart Circulation, November 1, 1995; 92(9): 2690 - 2696. [Abstract] [Full Text]
|
|